Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.18 | 13.62 | 16.24 | 13.34 | 16.26 | 14.93 | 18.54 | 15.72 | 18.66 | 18.37 | 18.90 | 19.44 |
| Expenses | 8.68 | 9.15 | 10.36 | 8.85 | 10.45 | 9.79 | 11.91 | 10.19 | 11.96 | 12.15 | 11.81 | 12.55 |
| Operating Profit | 4.50 | 4.47 | 5.88 | 4.49 | 5.81 | 5.14 | 6.63 | 5.53 | 6.70 | 6.22 | 7.09 | 6.89 |
| OPM % | 34.14% | 32.82% | 36.21% | 33.66% | 35.73% | 34.43% | 35.76% | 35.18% | 35.91% | 33.86% | 37.51% | 35.44% |
| Other Income | 0.74 | 0.68 | 0.84 | 0.86 | 1.07 | 1.10 | 1.08 | 1.17 | 1.20 | 1.16 | 1.46 | 1.33 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.22 | 0.42 | 0.46 | 0.48 | 0.47 | 0.48 | 0.47 | 0.49 | 0.50 | 0.51 | 0.50 | 0.52 |
| Profit before tax | 5.02 | 4.73 | 6.26 | 4.87 | 6.41 | 5.76 | 7.24 | 6.21 | 7.40 | 6.87 | 8.05 | 7.70 |
| Tax % | 25.70% | 23.26% | 25.56% | 25.26% | 24.49% | 22.40% | 27.49% | 25.44% | 24.73% | 25.04% | 24.72% | 24.94% |
| Net Profit | 3.74 | 3.64 | 4.66 | 3.65 | 4.84 | 4.46 | 5.25 | 4.63 | 5.57 | 5.15 | 6.06 | 5.78 |
| EPS in Rs | 3.12 | 3.03 | 3.88 | 3.04 | 4.03 | 3.72 | 4.37 | 3.86 | 4.64 | 4.29 | 5.05 | 4.82 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 19 | 23 | 28 | 38 | 50 | 56 | 63 | 72 | 75 |
| Expenses | 15 | 17 | 19 | 23 | 30 | 36 | 41 | 46 | 48 |
| Operating Profit | 4 | 5 | 9 | 15 | 20 | 20 | 22 | 26 | 27 |
| OPM % | 20% | 23% | 32% | 40% | 40% | 36% | 35% | 36% | 36% |
| Other Income | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 5 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 4 | 6 | 9 | 16 | 21 | 21 | 24 | 29 | 30 |
| Tax % | 20% | 20% | 23% | 28% | 25% | 25% | 25% | 25% | |
| Net Profit | 3 | 5 | 7 | 12 | 16 | 16 | 18 | 21 | 23 |
| EPS in Rs | 1,049.12 | 1,757.89 | 252.98 | 9.64 | 13.09 | 13.43 | 15.16 | 17.85 | 18.80 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 8% | 7% | 7% | 6% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 20% | 13% | 15% | ||
| Compounded Profit Growth | % | 24% | 11% | 18% | ||
| Stock Price CAGR | % | 16% | -5% | -29% | ||
| Return on Equity | % | 21% | 19% | 19% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.29 | 0.29 | 0.29 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 10 | 15 | 22 | 45 | 61 | 77 | 94 | 114 |
| Borrowings | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
| Other Liabilities | 4 | 4 | 7 | 6 | 6 | 6 | 7 | 8 |
| Total Liabilities | 15 | 21 | 31 | 64 | 79 | 95 | 113 | 134 |
| Fixed Assets | 5 | 5 | 5 | 7 | 7 | 27 | 27 | 27 |
| CWIP | 0 | 0 | 2 | 5 | 17 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 1 | 1 | 2 | 5 | 9 |
| Other Assets | 10 | 16 | 23 | 52 | 53 | 66 | 81 | 98 |
| Total Assets | 15 | 21 | 31 | 64 | 79 | 95 | 113 | 134 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 3 | 5 | 9 | 7 | 10 | 11 | 15 | 16 |
| Cash from Investing Activity | -1 | -1 | -2 | -4 | -12 | -2 | -2 | -2 |
| Cash from Financing Activity | 0 | 0 | -1 | 23 | -1 | -0 | -1 | -1 |
| Net Cash Flow | 2 | 4 | 6 | 26 | -3 | 9 | 12 | 12 |
| Free Cash Flow | 2 | 4 | 7 | 2 | -3 | 8 | 13 | 14 |
| CFO/OP | 96% | 115% | 118% | 75% | 79% | 80% | 94% | 87% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 35 | 48 | 22 | 31 | 53 | 45 | 45 |
| Inventory Days | 28 | 59 | 59 | 122 | 139 | 162 | 208 | 235 |
| Days Payable | 70 | 72 | 181 | 61 | 40 | 34 | 42 | 54 |
| Cash Conversion Cycle | 4 | 22 | -74 | 83 | 130 | 181 | 211 | 227 |
| Working Capital Days | 10 | 20 | 3 | 41 | 64 | 80 | 81 | 89 |
| ROCE % | 45% | 47% | 40% | 32% | 27% | 25% | 25% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% | 73.60% |
| FIIs | 0.31% | 0.31% | 0.52% | 1.11% | 0.63% | 0.63% | 0.63% | 0.63% | 0.63% | 0.65% | 0.65% | 0.65% |
| DIIs | 0.71% | 0.68% | 0.68% | 0.68% | 0.68% | 0.71% | 1.28% | 1.22% | 0.75% | 0.77% | 0.77% | 0.79% |
| Public | 25.37% | 25.40% | 25.20% | 24.61% | 25.09% | 25.07% | 24.49% | 24.54% | 25.01% | 24.97% | 24.97% | 24.94% |
| No. of Shareholders | 1,937 | 2,040 | 1,991 | 1,896 | 1,822 | 1,832 | 1,887 | 1,928 | 1,888 | 1,957 | 1,960 | 1,975 |
Fundamentals
Market Cap₹ 462 Cr.
Current Price₹ 385
Stock P/E20.5
Book Value₹ 105
ROCE24.9 %
ROE18.5 %
Dividend Yield0.26 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)15%
Compounded Profit Growth (TTM)18%
Standalone figures.
Valuation
Market capRs 453 Cr
Enterprise valueRs 404 Cr
P/E (TTM)20.06x
Price to book5.11x
Price to sales6.00x
EV / EBITDA12.53x
EV / EBIT13.37x
EV / sales5.36x
Price to cash flow39.39x
Earnings yield4.98%
Dividend yield0.27%
P/E, 3-year average28.33x
P/B, 3-year average5.65x
P/E, 5-year average28.33x
P/B, 5-year average5.65x
Profitability
Operating margin (excl. other income)35.51%
Operating margin (incl. other income)40.57%
EBITDA margin42.80%
Pre-tax margin39.83%
Net profit margin29.93%
Net margin, latest quarter29.73%
ROE19.98%
ROCE26.79%
ROA18.59%
ROE, 3-year average24.42%
ROCE, 3-year average32.90%
ROA, 3-year average21.67%
ROE, 5-year average30.10%
ROCE, 5-year average38.26%
ROA, 5-year average24.08%
ROIC (approx.)56.63%
Tax rate24.75%
Other income / net worth3.23%
Growth
Sales growth (latest year)13.22%
Profit growth (latest year)2.61%
Sales CAGR, 3 years25.71%
Sales CAGR, 5 years23.96%
Profit CAGR, 3 years30.76%
Profit CAGR, 5 years40.07%
Sales growth QoQ2.86%
Profit growth QoQ-4.62%
Sales growth YoY (latest quarter)23.66%
Profit growth YoY (latest quarter)24.84%
Per share
EPS (TTM)Rs 18.80
EPS (latest year)Rs 13.43
EPS (latest quarter)Rs 4.82
EPS, 3-year averageRs 12.05
EPS, 5-year averageRs 92.99
Book value per shareRs 73.81
Sales per shareRs 62.79
Cash flow per shareRs 9.57
Free cash flow per shareRs 11.66
Dividend per share (latest year)Rs 1.00
Dividend per share, 3-year averageRs 1.00
Dividend per share, 5-year averageRs 1.00
Dividends
Dividend payout7.44%
Dividend payout, 3-year average7.54%
Dividend payout, 5-year average7.54%
Efficiency
Asset turnover0.60x
Fixed asset turnover2.11x
Inventory turnover2.45x
Inventory days149 days
Debtor days53 days
Debtors turnover6.91x
Creditor days54 days
Cash conversion cycle227 days
Working capital days89 days
Leverage
Cash and bankRs 48 Cr
Net debtRs -48 Cr
Net debt / EBITDA-1.50x
Interest coverage143.95x
Owners' fund to total sources93.45%
Cash flow
Cash from Operating Activity (latest year)Rs 11 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 9 Cr
Free cash flow (latest year)Rs 14 Cr
Cash from ops / profit, 5 years0.71x
Sales to cash flow4.91x
Statement figures
Net sales (TTM)Rs 75 Cr
Net sales (latest year)Rs 56 Cr
Sales (latest quarter)Rs 19 Cr
Operating profit excl. other income (latest year)Rs 20 Cr
Operating profit (latest quarter)Rs 7 Cr
Other income (TTM)Rs 5 Cr
EBITDA (TTM)Rs 32 Cr
PBDT (TTM)Rs 32 Cr
Profit before tax (TTM)Rs 30 Cr
Tax (latest year)Rs 5 Cr
Net profit (TTM)Rs 23 Cr
Net profit (latest year)Rs 16 Cr
Net profit (latest quarter)Rs 6 Cr
Depreciation (TTM)Rs 2 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 15 Cr
Total expenditure (latest year)Rs 36 Cr
Total income (latest year)Rs 59 Cr
Share capitalRs 12 Cr
ReservesRs 77 Cr
Shareholders' fundsRs 89 Cr
Total assetsRs 95 Cr
Net blockRs 27 Cr
InvestmentsRs 2 Cr
ReceivablesRs 8 Cr
InventoryRs 6 Cr
Other liabilitiesRs 6 Cr
Shares outstanding (crore)1.20
Ownership
Promoter holding73.60% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 20.1 is at the 2th percentile of its own 5.1-year range
(median 65.1, low 19.9, high 174.1).
P/B 5.11 is at the 2th percentile (median 20.39).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 543363 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -0.5% | -2.8% | +2.3 pts |
| 1 month | -4.4% | -6.8% | +2.4 pts |
| 3 months | +0.3% | -7.6% | +7.9 pts |
| 3 years | -17.1% | +14.2% | -31.3 pts |
| 5 years | +100.0% | +27.9% | +72.1 pts |
Red flags
F-score 4 of 8| explain | Receivables outrunning sales Receivables grew 90% vs sales +13% in 2026 |
| explain | Share dilution Share count up 0% in a year, 3900% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹19 Cr +23.7% vs Jun 2025.
Net profit ₹6 Cr +24.8%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Poly Medicure Ltd | 16,671 | 52.1 | 12.5 % |
| Molbio Diagnostics Ltd | 14,470 | 66.6 | 18.0 % |
| Fischer Medical Ventures Ltd | 2,355 | 96.2 | 11.4 % |
| Tarsons Products Ltd | 1,754 | 148 | 4.59 % |
| Q-Line Biotech Ltd | 1,569 | 27.8 | 22.5 % |
| Laxmi Dental Ltd | 1,058 | 30.4 | 15.0 % |
| Hemant Surgical Industries Ltd | 869 | 51.3 | 18.9 % |
| Vasa Denticity Ltd | 754 | 62.3 | 7.54 % |
| OSEL Devices Ltd | 691 | 23.6 | 24.4 % |
| QMS Medical Allied Services Ltd | 419 | 39.0 | 12.9 % |
| Nureca Ltd | 349 | 80.4 | 3.30 % |
| Aprameya Engineering Ltd | 200 | 39.7 | 12.6 % |
| Avience Biomedicals Ltd | 198 | 22.7 | 27.0 % |
| Earkart Limited | 179 | 36.3 | 17.5 % |
| Vaidya Sane Ayurved Laboratories Ltd | 176 | 19.6 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Prevest Denpro Ltd?
Prevest Denpro Ltd (543363) has a market capitalisation of Rs 462 Cr. at the 2026-10-01 close.
What is the P/E ratio of Prevest Denpro Ltd?
Prevest Denpro Ltd trades at a P/E of 20.5 on trailing twelve-month profit, at the 2026-10-01 close.
What were Prevest Denpro Ltd's latest quarterly results?
In the Jun 2026 quarter, Prevest Denpro Ltd sales was Rs 19 Cr (+23.7% vs Jun 2025) and net profit was Rs 6 Cr.